A detailed history of Kestra Investment Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Kestra Investment Management, LLC holds 10,511 shares of BMY stock, worth $491,389. This represents 0.02% of its overall portfolio holdings.

Number of Shares
10,511
Previous 7,829 34.26%
Holding current value
$491,389
Previous $443 Million 44.77%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 16, 2025

BUY
$53.9 - $63.11 $485 - $567
9 Added 0.09%
10,520 $642 Million
Q1 2025

May 15, 2025

BUY
$53.9 - $63.11 $144,559 - $169,261
2,682 Added 34.26%
10,511 $641 Million
Q4 2024

Jan 31, 2025

BUY
$51.92 - $59.94 $200,047 - $230,948
3,853 Added 96.91%
7,829 $443 Million
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $157,688 - $205,758
3,976 New
3,976 $206 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.4B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Kestra Investment Management, LLC Portfolio

Follow Kestra Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Investment Management, LLC with notifications on news.